Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy
David M. Horton, Blaise Morrison, Judy A. Schmidt
American Journal of Psychotherapy July 23, 2021 DOI: 10.1176/appi.psychotherapy.20200055 via OpenAlex
Summary
AI-generated from the abstractA systematized review of clinical trials on psychedelic-assisted psychotherapy (PAP) published over the past 25 years found important commonalities among the studies but also revealed key differences in how psychotherapy was incorporated into PAP. The authors conclude that additional research is needed to identify the unique effect of psychotherapy in PAP.
Study at a glance
| Characteristics | Systematized review Peer reviewed |
|---|---|
| Duration | Past 25 years |
| Topics | Psilocybin |
| Keywords | Psychotherapist Psycinfo Clinical trial Clinical psychology |
| Citations | 92 |
| Key finding | Important commonalities exist among clinical trials of PAP, but key differences in how psychotherapy is incorporated into PAP remain, and more research is needed to identify the unique effect of psychotherapy. |
Abstract
This systematized review found important commonalities among clinical trials of PAP published within the past 25 years and revealed key differences among studies in psychotherapy's incorporation into PAP. Additional research is needed to identify the unique effect of psychotherapy in PAP.